Recombinant human insulin (Biocon)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human insulin (Biocon)
Drug Alias NameInsulin biosimilar (Biocon)Recombinant human insulin-BioconInsugen
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionInsulin receptor agonistsPhosphokinases stimulantsOrnithine decarboxylase stimulants
TargetsPhosphokinasesInsulin receptorOrnithine decarboxylase
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsDiabetes Mellitus
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2004/11/10
Country/TerritoryGermanyIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBiocon Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBiocon LtdMinistry of Health Malaysia
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeA10AB01A10AC01A10AD01 +[5] 
Related LinksN/A